切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2018, Vol. 12 ›› Issue (06) : 547 -552. doi: 10.3877/cma.j.issn.1674-1358.2018.06.006

所属专题: 文献

论著

乙型肝炎病毒表面抗原主蛋白与烯酰辅酶A水合酶相互作用对肝细胞胆固醇代谢的影响
张凯1, 姚雯1, 林苏1, 王明芳1, 朱月永1,()   
  1. 1. 350005 福州市,福建医科大学附属第一医院肝病中心
  • 收稿日期:2018-05-05 出版日期:2018-12-15
  • 通信作者: 朱月永
  • 基金资助:
    福建省自然科学基金项目(No. 2016Y0040); 福建省中青年教师教育科研项目(No. JA15207)

Impact of interactions between small hepatitis B virus surface antigen and enoyl co-enzyme A hydratase on cholesterol metabolism in hepatocytes

Kai Zhang1, Wen Yao1, Su Lin1, Mingfang Wang1, Yueyong Zhu1,()   

  1. 1. Liver Research Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
  • Received:2018-05-05 Published:2018-12-15
  • Corresponding author: Yueyong Zhu
  • About author:
    Corresponding author: Zhu Yueyong, Email:
引用本文:

张凯, 姚雯, 林苏, 王明芳, 朱月永. 乙型肝炎病毒表面抗原主蛋白与烯酰辅酶A水合酶相互作用对肝细胞胆固醇代谢的影响[J]. 中华实验和临床感染病杂志(电子版), 2018, 12(06): 547-552.

Kai Zhang, Wen Yao, Su Lin, Mingfang Wang, Yueyong Zhu. Impact of interactions between small hepatitis B virus surface antigen and enoyl co-enzyme A hydratase on cholesterol metabolism in hepatocytes[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2018, 12(06): 547-552.

目的

探究乙型肝炎病毒表面抗原主蛋白(SHBs)与烯酰辅酶A水合酶(ECHS1)相互作用对肝细胞胆固醇代谢的影响。

方法

通过在人肝癌细胞株HepG2中瞬时转染SHBs,建立SHBs瞬时转染细胞模型,分别设置空白对照组、空质粒转染组、单纯SHBs转染组、SHBs +阴性序列对照组、ECHS1过表达组以及ECHS1干扰组。在转染后48 h检测ECHS1及载脂蛋白A1(ApoA1)基因的表达和各转染组转氨酶水平及细胞内总胆固醇(TC)含量。

结果

与空白组相比,单纯SHBs转染组在核酸水平ECHS1、ApoA1的表达均下降(P均< 0.001),蛋白水平表达趋势同核酸一致(P < 0.001、P = 0.0025),细胞内TC水平升高(P < 0.001),转氨酶水平升高(PALT < 0.001、PAST < 0.001)。较单纯SHBs转染组,ECHS1过表达组可在核酸和蛋白水平下调ApoA1(P = 0.0072、P < 0.001),且细胞内TC水平下降(P < 0.001),转氨酶水平降低(PALT < 0.001、PAST = 0.0049)。与单纯SHBs转染组相比较,ECHS1干扰组ApoA1核酸和蛋白水平亦降低(P = 0.0096、P < 0.001),TC水平降低(P < 0.001),ALT水平无显著变化(P = 0.28),AST水平升高(P = 0.0069)。

结论

SHBs能够通过下调ApoA1表达来提高肝细胞TC水平,同时ECHS1通过相关信号通路及分子机制抑制TC的生成。

Objective

To investigate the interactions between small hepatitis B virus surface protein (SHBs) and enoyl CoA hydratase short chain 1 (ECHS1) on cholesterol metabolism in hepatocytes.

Methods

Human hepatocellular carcinoma HepG2 cells were transfected with SHBs transiently, and then assigned into the blank control group, the blank plasmid transfection group, the SHBs transfection group, the SHBs + negative sequence control group, the ECHS1 overexpression group and the ECHS1 interference group. The expression of ECHS1 and apolipoprotein A1 (ApoA1) were detected, and the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and intracellular total cholesterol (TC) were measured 48 hours post-transfection.

Results

Significantly lower ECHS1 and ApoA1 expression were detected in the SHBs transfection group than those of the blank control group at both translational (both P < 0.001) and transcriptional levels (P < 0.001, P = 0.0025), and higher intracellular TC (P < 0.001) and serum ALT (P < 0.001) and AST levels (P < 0.001) were measured in SHBs transfection group than those of the blank control group. In addition, lower ApoA1 protein (P = 0.0072) and mRNA expression (P < 0.001), lower intracellular TC levels (P < 0.001), lower serum ALT (P < 0.001) and AST concentrations levels (P = 0.0049) were found in the ECHS1 overexpression group than those in the SHBs transfection group; meanwhile, compared with SHBs transfection group, there were significantly lower ApoA1 nucleic acid and protein levels (P = 0.0096, P < 0.001), decreased TC level (P < 0.001), no significant change of ALT level (P = 0.28), and increased AST level (P = 0.0069) in ECHS1 interference group.

Conclusions

SHBs increases TC levels through downregulating ApoA1 expression in hepatocytes, and ECHS1 may suppress TC production through some signal pathways and molecular mechanism.

图1 质粒pcDNA3.1(+)-SHBs双酶切与质粒pcDNA3.1(+)-ECHS1双酶切电泳图及转染细胞中SHBs基因mRNA的表达
图2 不同转染组HepG2细胞中APOA1 mRNA和蛋白表达水平
图3 不同转染组细胞转染48 h后细胞脂质水平
[1]
刘璐璐,任艺,何毅怀, 等. 慢性乙型肝炎合并非酒精性脂肪性肝病的研究进展[J]. 临床肝胆病杂志,2017,33(3):538-542.
[2]
Wang MM, Wang GS, Shen F, et al. Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factors[J]. Digest Dis Sci,2014,59(10):2571-2579.
[3]
王明芳,林苏,吴银莲, 等. 慢性乙型肝炎患者肝脂肪变性与血清,肝组织病毒因素的关系[J]. 中华传染病杂志,2016,34(3):141-145.
[4]
Lin CW, Huang XL, Liu HL, et al. Interactions of hepatitis B virus infection with nonalcoholic fatty liver disease: possible mechanisms and clinical impact[J]. Digest Dis Sci,2015,60(12):3513-3524.
[5]
路然,洪天配. 脂质代谢紊乱导致非酒精性脂肪性肝病的发病机制[J]. 临床肝胆病杂志,2015,31(7):1050-1054.
[6]
Day CP, James OF. Steatohepatitis: a tale of two "hits" ?[J].Gastroenterology,1998,114(4):842-845.
[7]
Kawano Y, Cohen DE. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease[J]. J Gastroenterol, 2013,48(4):434-441.
[8]
马振增,陆伦根. 胆固醇代谢与非酒精性脂肪性肝炎[J]. 中华肝脏病杂志,2016,24(8):623-627.
[9]
Perla FM, Prelati M, Lavorato M, et al. The role of lipid and lipoprotein metabolism in non-alcoholic fatty liver disease[J]. Children,2017,4(6):46-58.
[10]
Honer Zu Siederdissen C, Maasoumy B, Cornberg M. What is new on HBsAg and other diagnostic markers in HBV infection?[J]. Best Pract Res Cl Ga,2017,31(3):281-289.
[11]
Blanchet M, Sureau C. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity[J]. J Virol,2006,80(24):11935-11945.
[12]
周飞,任建林,卢雅丕, 等. 酵母双杂交法对HBV表面抗原主蛋白候选结合蛋白的筛选[J]. 世界华人消化杂志,2008,16(13):1378-1382.
[13]
饶紫兰,董菁,朱月永, 等. 乙型肝炎病毒表面抗原主蛋白对HepG2细胞脂代谢基因表达的影响[J]. 中华肝脏病杂志,2013,21(8):624-630.
[14]
Gong X, Zhu Y, Dong J, et al. Small hepatitis B surface antigen interacts with and modulates enoyl-coenzyme A hydratase expression in hepatoma cells[J]. Arch Virol,2013,158(5):1065-10670.
[15]
朱小三,戴益琛. ECHS1的表达异常与临床的关系[J]. 医学分子生志,2013,10(3):184-186.
[16]
Wu L, Lin S, Li D. Comparative inhibition studies of enoyl-CoA hydratase 1 and enoyl-CoA hydratase 2 in long-chain fatty acid oxidation[J]. Org Lett,2008,10(15):3355-3358.
[17]
Zhang S, Du T, Li M, et al. Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects[J]. Medicine,2017,96(22):e7041.
[18]
Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis[J]. N Engl J Med,2017,377(21):2063-2072.
[19]
Kim KH, Shin HJ, Kim K, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma[J]. Gastroenterology,2007,132(5):1955-1967.
[20]
Xiao CX, Yang XN, Huang QW, et al. ECHS1 acts as a novel HBsAg-binding protein enhancing apoptosis through the mitochondrial pathway in HepG2 cells[J]. Cancer Lett,2013,330(1):67-73.
[21]
Zhang X, Yang J, Guo Y, et al. Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis[J]. Hepatology(Baltimore, Md),2010,51(4):1190-1199.
[22]
姚雯. 乙型肝炎病毒表面抗原主蛋白与烯酰辅酶A水合酶相互作用对细胞脂代谢影响的研究[D]. 福建医科大学,2015.
[23]
Andreas G. Hepatitis B virus induces expression of cholesterol metabolism-related genes via TLR2 in HepG2 cells[J]. World J Gastroenterol,2013,19(14):2262-2269.
[24]
Li YJ, Zhu P, Liang Y, et al. Hepatitis B virus: the "metabolovirus" highjacks cholesterol and bile acid metabolism[J]. Hepatology(Baltimore, Md),2014,60(5):1458-1460.
[25]
Bremer C, Bung C, Kott N, et al. Hepatitis B virus infection is dependent on cholesterol in the viral envelope[J]. Cell Microbiol,2010,11(2):249-260.
[26]
莫中成,欧含笑,易光辉. 载脂蛋白A-Ⅰ在高密度脂蛋白生物合成中的作用研究进展[J]. 生物化学与生物物理进展,2015,42(9):788-795.
[27]
高国生,董飞波,颜卫华. 血清载脂蛋白A-1检测在HBV相关肝癌中的临床价值[J]. 医学研究杂志,2017,46(4):109-112.
[28]
Jiang W, Zheng L, Yang Q, et al. Investigation into the effect of hepatitis B virus on apoliprotein A1 expression and its mechanism[J]. Lipids Health Dis,2014,13(1):130-135.
[29]
Wang Y, Hao J, Liu X, et al. The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus[J]. Lipids Health Dis,2016,15(1):1-7.
[1] 王敏, 薛同敏, 刘伟, 张攀, 肖路, 张培建. 二氯化钴所致缺氧对HepG2细胞增殖抑制和凋亡的影响[J]. 中华普通外科学文献(电子版), 2016, 10(05): 346-349.
[2] 沈歌前, 阚敬保, 张日华, 刘云. 钙结合蛋白S100A16对胰岛素抵抗的作用研究[J]. 中华细胞与干细胞杂志(电子版), 2020, 10(01): 44-48.
阅读次数
全文


摘要